ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Artificial intelligence promotes the diagnosis and screening of diabetic retinopathy

Huang, Xuan; Wang, Hui; She, Chongyang; Feng, Jing; Liu, Xuhui; Hu, Xiaofeng; Chen, Li; Tao, Yong*capital med univ
Frontiers in Endocrinology2022-9-29DOI: 10.3389/fendo.2022.946915
24被引7阅读
引用收藏
分享

摘要

Deep learning evolves into a new form of machine learning technology that is classified under artificial intelligence (AI), which has substantial potential for large-scale healthcare screening and may allow the determination of the most appropriate specific treatment for individual patients. Recent developments in diagnostic technologies facilitated studies on retinal conditions and ocular disease in metabolism and endocrinology. Globally, diabetic retinopathy (DR) is regarded as a major cause of vision loss. Deep learning systems are effective and accurate in the detection of DR from digital fundus photographs or optical coherence tomography. Thus, using AI techniques, systems with high accuracy and efficiency can be developed for diagnosing and screening DR at an early stage and without the resources that are only accessible in special clinics. Deep learning enables early diagnosis with high specificity and sensitivity, which makes decisions based on minimally handcrafted features paving the way for personalized DR progression real-time monitoring and in-time ophthalmic or endocrine therapies. This review will discuss cutting-edge AI algorithms, the automated detecting systems of DR stage grading and feature segmentation, the prediction of DR outcomes and therapeutics, and the ophthalmic indications of other systemic diseases revealed by AI.

学科与关键词

关键词
diabetic retinopathyartificial intelligenceclassificationsegmentationdiagnosisscreeningprediction
相关
加载中…
  • Artificial Intelligence Screening for Diabetic Retinopathy: the Real-World Emerging Application
    Bellemo, Valentina; Lim, Gilbert; Rim, Tyler Hyungtaek; Tan, Gavin S. W.; Cheung, Carol Y.; Sadda, SriniVas; He, Ming-guang; Tufail, Adnan; Lee, Mong Li; Hsu, Wynne; Ting, Daniel Shu Wei*Current Diabetes Reports, 2019, 19(9): 72.被引 104
  • Artificial intelligence in retina
    Schmidt-Erfurth, Ursula*; Sadeghipour, Amir; Gerendas, Bianca S.; Waldstein, Sebastian M.; Bogunovic, HrvojePROGRESS IN RETINAL AND EYE RESEARCH, 2018, 67: 1-29.被引 460
  • Different fundus imaging modalities and technical factors in AI screening for diabetic retinopathy: a review
    Lim, Gilbert; Bellemo, Valentina; Xie, Yuchen; Lee, Xin Q.; Yip, Michelle Y. T.; Ting, Daniel S. W.*Eye and Vision, 2020, 7(1): 21.被引 53
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Endocrinology
发表日期
2022-09-29
卷期
第 13 卷
页码
946915
DOI
10.3389/fendo.2022.946915
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China; Scientific Research Program of Beijing Municipal Commission of Education; Shunyi District "Beijing Science and technology achievements transformation coordination and service platform" construction fund; [32000485]; [62006161]; [82070948]; [KM202010025020]; [SYGX202010]

作者

  • H

    Huang, Xuan (第一作者)

    capital med univ

  • W

    Wang, Hui

    capital med univ

查看全部 8 位作者收起作者
  • S

    She, Chongyang

    capital med univ

  • F

    Feng, Jing

    capital med univ

  • L

    Liu, Xuhui

    capital med univ

  • H

    Hu, Xiaofeng

    capital med univ

  • C

    Chen, Li

    capital med univ

  • T

    Tao, Yong (通讯)

    capital med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417